Tag: NASD:LIXT
US Equity Markets

Lixte Biotechnology (LIXT) Shares Climb Sharply On Equity Deal Closure

Following the successful conclusion of a $5.0 million private placement, Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) saw a notable spike in its share price on Wednesday, ending at $2.02, representing a dramatic jump of 71.19%. In line with Nasdaq’s market-based

Comet Report delivers independent, unbiased news. Our dedicated journalists bring you the truth, sparking curiosity and igniting conversation. Join us – illuminate the world with Comet.

Quick Links

Categories

Copyrights © 2024 Comet Report, All rights reserved.

Comet Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.